| Day High | $28.25 |
|---|---|
| Day Low | $28.23 |
| 52-Week High | $28.25 |
| 52-Week Low | $15.92 |
Is Stellantis a buy now?
Consensus Rating. Stellantis has received a consensus rating of Buy. The company's average rating score is 2.58, and is based on 7 buy ratings, 5 hold ratings, and no sell ratings.
What is Market Cap in Stock?
Market cap—or market capitalization—refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares. For example, a company with 20 million shares selling at $50 a share would have a market cap of $1 billion.
What is a good dividend yield?
2% to 4%What is a good dividend yield? In general, dividend yields of 2% to 4% are considered strong, and anything above 4% can be a great buy—but also a risky one. When comparing stocks, it's important to look at more than just the dividend yield.
Which company share is best?
Top 10 Companies to Invest in India on the Basis of Market ValueS.No.Company NameIndustry1.Reliance Industries Ltd.Multinational Conglomerate2.Tata Consultancy Services Ltd.Information Technology3.HDFC Bank Ltd.Banking4.ITC Ltd.FMCG21 more rows•Jun 9, 2022
Is it good if market cap is high?
The Advantages of Large-Cap Stocks Investors see them as more attractive on account of their stability and also the fact that they tend to offer consistent dividends. That makes them a better bet for conservative investors.
Why is market cap so important?
Market cap allows investors to size up a company based on how valuable the public perceives it to be. The higher the value, the "bigger" the company. The size and value of a company can inform the level of risk you might expect when investing in its stock, as well as how much your investment might return over time.
How does market cap affect stock price?
Market cap does not influence share prices. It works the other way around. Market cap is arrived at by multiplying the share price by the number of shares outstanding. So when a stock's price rises, so too does its market cap.
What is a good market value?
The price-to-book (P/B) ratio has been favored by value investors for decades and is widely used by market analysts. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Should I buy or sell Intersect ENT stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intersect ENT in the last twelve months. There are currently 3 hold rating...
What is Intersect ENT's stock price forecast for 2022?
3 analysts have issued 1-year target prices for Intersect ENT's stock. Their forecasts range from $28.25 to $28.30. On average, they predict Inters...
How has Intersect ENT's stock performed in 2022?
Intersect ENT's stock was trading at $27.31 at the start of the year. Since then, XENT stock has increased by 3.4% and is now trading at $28.24. V...
When is Intersect ENT's next earnings date?
Intersect ENT is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Inters...
How were Intersect ENT's earnings last quarter?
Intersect ENT, Inc. (NASDAQ:XENT) announced its earnings results on Tuesday, November, 2nd. The medical equipment provider reported ($0.48) earning...
Who are Intersect ENT's key executives?
Intersect ENT's management team includes the following people: Mr. Thomas A. West , Pres, CEO & Director (Age 58, Pay $908.97k) Mr. Richard A. M...
What is Thomas West's approval rating as Intersect ENT's CEO?
7 employees have rated Intersect ENT CEO Thomas West on Glassdoor.com . Thomas West has an approval rating of 41% among Intersect ENT's employees....
Who are some of Intersect ENT's key competitors?
Some companies that are related to Intersect ENT include Inari Medical (NARI) , Haemonetics (HAE) , Merit Medical Systems (MMSI) , NuVasive (NU...
What other stocks do shareholders of Intersect ENT own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Intersect ENT investors own include SEASPAN CORP/SH SH (SS...
Component Grades
XENT POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
XENT Stock Summary
Quality is the dimension where XENT ranks best; there it ranks ahead of 56.86% of US stocks.
XENT Valuation Summary
Intersect ENT Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.9% of US listed stocks.
XENT's Quality Factors
XENT's price/sales ratio is 8.8; this is 22.47% lower than that of the median Healthcare stock.
Latest XENT News From Around the Web
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
Continue Researching XENT
Below are the latest news stories about Intersect ENT Inc that investors may wish to consider to help them evaluate XENT as an investment opportunity.
Barchart Technical Opinion
Want to see what other sources are saying about Intersect ENT Inc's financials and stock price? Try the links below:
Business Summary
The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.
